glp-1 age limit for Teens: Safety, Limits & Biomarker Context – PlexusDx GLP-1 Agonists For Obesity In

Pancreatitis In clinical trials of lixisenatide there were 21 cases of pancreatitis among lixisenatide-treated patients and 14 cases in comparator-treated patients (incidence rate of 21 vs 17 per 10,000 patient-years)

Endocrinology, 2025

This article explains how Ipamorelin and GHRP-2 work in the body, highlights key differences between them, summarizes research findings, and notes their potential performance-related impacts

GLP-1 Users Faced Up to 68% Higher Hair Loss Risk After accounting for those differences, people on GLP-1 drugs were about 37% more likely to be diagnosed with hair loss than people on SGLT-2 inhibitors, and about 68% more likely than people on DPP-4 inhibitors

ISSN 1175-0561

Mean eGFR was 90.6 mL/min/1.73 m 2 (SD 19.3) and median UACR was 14.6 mg/g [IQR 0.054.7]